AddLife
Logotype for AddLife

AddLife (ALIF) investor relations material

AddLife Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for AddLife
Q4 2025 earnings summary4 Feb, 2026

Executive summary

  • EBITA and EBITDA margins improved across both Labtech (14.1%) and Medtech (12.0%), with overall margin at 12.4% in Q4 and 12.1% for the year, driven by profit growth and operational efficiency.

  • Organic and acquired revenue growth was 2% in Q4, with full-year net sales up 2% to SEK 10,442m; profit before tax increased 129% in Q4, and profit after tax rose 121% for the year.

  • Divestment of the UK endoscopy business generated SEK 158 million, supporting significant net debt reduction and balance sheet strength.

  • Three acquisitions (Pharmacold, Opitek, Edge Medical) were completed, supporting strategic growth and future expansion.

  • Currency effects negatively impacted reported sales and EBITA/EBITDA, but underlying organic and acquired growth remained positive.

Financial highlights

  • Adjusted EBITA increased 8% to SEK 1,259m, with an adjusted EBITA margin of 12.1%; EBITA (including divestments) rose 22% to SEK 1,417m.

  • Q4 organic and acquired revenue growth was 2%, with adjusted EBITDA growth of 5%; net sales reached SEK 2,733m in Q4.

  • Operating cash flow was nearly SEK 900 million in Q4 and SEK 1.4 billion for the year, up 27% year-over-year.

  • Net debt/EBITDA reduced to 2.2, well below the target of 3, and net debt/equity ratio improved to 0.7.

  • Inventory to sales improved to 16% from 17% in 2024.

Outlook and guidance

  • Management expects continued margin improvement and profit growth, with ongoing focus on high-margin products and operational efficiency.

  • Strengthened balance sheet enables increased acquisition activity, with a healthy M&A pipeline and plans for more acquisitions in 2026.

  • Positive outlook for 2026, supported by robust demand for advanced healthcare products and a proposed dividend increase.

Describe the expected scale of 2026 acquisitions
Medtech: How to offset divested UK endoscopy sales?
Labtech's 5% organic growth: key drivers?
What M&A contribution is targeted for 2026?
What specific margin initiatives are driving Medtech?
How will divested endoscopy revenue be replaced?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next AddLife earnings date

Logotype for AddLife
Q1 202628 Apr, 2026
AddLife
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next AddLife earnings date

Logotype for AddLife
Q1 202628 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

AddLife AB, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. AddLife's products are used in the development of cell therapies: cellular immunotherapy for autoimmune disease at institutions such as Scripps Research Institute Florida; clinical translation for Dystrophin gene therapy by partners such as Nationwide Children's Hospital; and phenotyping services for clinical researchers at Rush University Medical Center. It also offers products for biopharmaceutical development, including cell sorters from Abacus Biosystems; high-content screening plates for use in the drug discovery process; and automated microscope slide stainer products for automated image analysis and high content analysis. The company is based in Stockholm, Sweden.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage